source
- House panel calls to ban China data from FDA drug trial applicationsA powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in future applications by drugmakers to test new treatments. The language wasEndpoints · 3mo ago↗ source
- Court dismisses part of Lilly lawsuit against Empower, some claims can proceedA federal judge has dismissed part of Eli Lilly’s lawsuit alleging Empower Pharmacy misled customers about its compounded versions of the obesity drug tirzepatide. But the court said some of Lilly’…Endpoints · 3mo ago↗ source
- Supreme Court questions how far generics makers can go with 'skinny label' drugsWASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the pharmaceutical industry. In its final argument scheduled for this term, the high court…